LivaNova

Recent news

• Rating change
  Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $81
  Market Newswire · 2026/2/26
• Rating change
  KeyBanc Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $92
  Market Newswire · 2026/6/22
• Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90
  Market Newswire · 2026/9/2
• Rating change
  Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $85
  Market Newswire · 2026/4/13
• Rating change
  Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (LIVN), Gain Therapeutics (GANX) and Tempus AI, Inc. Class A (TEM)
  TipRanks · 2026/7/2
• Rating change
  Goldman Sachs Maintains LivaNova(LIVN.US) With Hold Rating, Maintains Target Price $73
  Market Newswire · 2026/2/27
• Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $87
  Market Newswire · 2026/6/23
• Rating change
  Stifel Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $80
  Market Newswire · 2026/2/26
• Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $93
  Market Newswire · 2026/8/6
• Rating change
  A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $72 to $90
  Market Newswire · 2026/5/7
• Rating change
  KeyBanc Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81
  Market Newswire · 2026/1/26
• Rating change
  Baird Maintains LivaNova(LIVN.US) With Buy Rating, Cuts Target Price to $76
  Market Newswire · 2026/5/8
• Rating change
  Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90
  Market Newswire · 2026/5/8
• Rating change
  Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81
  Market Newswire · 2026/3/19
• Rating change
  Barclays Maintains LivaNova(LIVN.US) With Hold Rating, Raises Target Price to $67
  Market Newswire · 2026/1/9
• Rating change
  Goldman Sachs Maintains LivaNova(LIVN.US) With Hold Rating, Raises Target Price to $73
  Market Newswire · 2026/2/26
• Rating change
  Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $85
  Market Newswire · 2026/2/19
• Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $95
  Market Newswire · 2026/7/15
• Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating
  Market Newswire · 2026/8/21
• Rating change
  A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $73 to $85
  Market Newswire · 2026/2/27

Headlines are aggregated automatically and are not independently verified or edited by our team.